Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Portuguese · SciRah

Researcher profile · Semantic Scholar

A. Portuguese

Share profile

A. Portuguese — researcher profile on SciRah

h-index: 9
Works: 68
Citations: 359

Most-cited papers

Immune Checkpoint Inhibitor Use in Solid Organ Transplant Recipients: A Systematic Review.
A. Portuguese, S. Tykodi, Christopher D. Blosser, T. Gooley +2 more
2022The Journal of the National Comprehensive Cancer Network63 citations
Semantic Scholar
Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination
A. Portuguese, Cassandra Sunga, R. Kruse-Jarres, T. Gernsheimer +1 more
2021Blood Advances55 citations Open access
Semantic Scholar
Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Z. Bakouny, C. Labaki, P. Grover, J. Awosika +72 more
2022JAMA Oncology45 citations Open access
Semantic Scholar
Factors associated with long-term outcomes of CD19 CAR T-cell therapy for relapsed/refractory CLL
Emily C Liang, Aya Albittar, Jennifer J. Huang, A. Hirayama +12 more
2023Blood Advances35 citations Open access
Semantic Scholar
Successful treatment of immune checkpoint inhibitor-associated fulminant myocarditis with abatacept and ruxolitinib: a case report
E. Wadden, C. Lai, P. Grivas, S. Bhatia +4 more
2025European Heart Journal: Case Reports21 citations Open access
Semantic Scholar
Extramedullary disease is associated with severe toxicities following B-cell maturation antigen CAR T-cell therapy in multiple myeloma
A. Portuguese, Emily C. Liang, Jennifer J. Huang, Yein Jeon +11 more
2025Haematologica13 citations
Semantic Scholar
Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow-up
A. Portuguese, Jennifer J. Huang, Yein Jeon, Mahnoosh Taheri +17 more
2025Haematologica10 citations Open access
Semantic Scholar
Outcomes of Teclistamab (Tec) in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Prior Exposure to BCMA-Directed Therapy (BCMA-DT): A Multicenter Study from the U.S. Multiple Myeloma Immunotherapy Consortium
D. Dima, Mariola A. Vazquez-Martinez, James A. Davis, Utkarsh Goel +43 more
2024Blood10 citations
Semantic Scholar
Platelet trends after Covid-19 vaccination in patients with chronic or persistent immune thrombocytopenia
D. Jiang, A. Portuguese, Amanda Weatherford, David A. Garcia +1 more
2021American journal of hematology/oncology10 citations Open access
Semantic Scholar
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy Consortium
O. Pasvolsky, D. Dima, Lei Feng, Wen-Li Dong +47 more
2025Blood Cancer Journal9 citations Open access
Semantic Scholar
Real-World Comparison of Lisocabtagene Maraleucel (Liso-Cel) and Axicabtagene Ciloleucel (Axi-Cel): Efficacy & Toxicity
A. Portuguese, Aya Albittar, Jennifer J. Huang, Emily C. Liang +16 more
2024Transplantation and Cellular Therapy9 citations Open access
Semantic Scholar
Outcomes of Elderly Patients with Relapsed Refractory Multiple Myeloma (RRMM) Treated with Teclistamab: A Multicenter Study from the U.S. Multiple Myeloma Immunotherapy Consortium
O. Pasvolsky, D. Dima, Lei Feng, Wen-Li Dong +44 more
2024Blood7 citations
Semantic Scholar
T-Cell Large Granular Lymphocyte Population Involving Chimeric Antigen Receptor-Modified T (CAR T) Cells in Patients with Cytopenia after CD19-Targeted CAR T-Cell Therapy: Case Series
Aya Albittar, Alireza Torabi, Emily C. Liang, A. Portuguese +17 more
2024Transplantation and Cellular Therapy6 citations Open access
Semantic Scholar
Opportunities to improve antibiotic stewardship, and identification of blood biomarkers associated with bacteremia following CAR-T cell therapy.
Sai-Kit Ng, Patrick W Flaherty, Melissa Ancheta, Karyn A. Tindbaek +17 more
2025Transplantation and Cellular Therapy5 citations Open access
Semantic Scholar
Phase 2 Study of Anakinra to Prevent CRS and Neurotoxicity after Treatment with Lisocabtagene Maraleucel: Planned Interim Analysis
Emily C. Liang, Aya Albittar, A. Portuguese, Jennifer J. Huang +21 more
2023Blood5 citations Open access
Semantic Scholar
Immune-Effector Cell-Associated Enteritis/Colitis (IEC-EC) after Ciltacabtagene Autoleucel (cilta-cel) in Multiple Myeloma (MM): Updated Clinicopathologic Data and Management
Lekha Mikkilineni, Mark P. Hamilton, A. Kumar, Gliceida M Galarza-Fortuna +32 more
2026Transplantation and Cellular Therapy4 citations
Semantic Scholar
Optimizing Autologous Stem Cell Transplantation in Multiple Myeloma: The Impact of Intensive Chemomobilization
A. Portuguese, Albert C Yeh, Rahul Banerjee, L. Holmberg +7 more
2024Transplantation and Cellular Therapy4 citations Open access
Semantic Scholar
P-071 Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the U.S. Myeloma Immunotherapy Consortium
Beatrice M Razzo, A. Grajales-Cruz, S. Atrash, Christopher J. Ferreri +21 more
2024Clinical Lymphoma, Myeloma & Leukemia4 citations
Semantic Scholar
Early prediction of severe ICANS after standard-of-care CD19 CAR T-cell therapy using gradient-boosted classification trees.
Jennifer J. Huang, Emily C. Liang, Aya Albittar, A. Portuguese +16 more
2024Journal of Clinical Oncology4 citations
Semantic Scholar
Predictors and Characterization of Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) in Patients with Multiple Myeloma Receiving Teclistamab
O. Pasvolsky, Aimaz Afrough, Lei Feng, Wen-Li Dong +43 more
2024Blood4 citations
Semantic Scholar
Chimeric Antigen Receptor T cells for Multiple Myeloma: The Journey So Far – And the Road Ahead
A. Cowan, S. Tuazon, A. Portuguese, D. Green
2021Cancer Journal4 citations Open access
Semantic Scholar
A Case Report: Point-of-care Ultrasound in the Diagnosis of Post-Myocardial Infarction Ventricular Septal Rupture
A. Portuguese, Khaled H. Abdulla, Michael Vornovitsky, John DeAngelis
2020Clinical Practice and Cases in Emergency Medicine4 citations Open access
Semantic Scholar
Teclistamab (Tec) for Patients (pts) with Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment: A Multicenter Study from the U.S. Multiple Myeloma Immunotherapy Consortium
D. Dima, Aimaz Afrough, Utkarsh Goel, A. Grajales-Cruz +40 more
2025Transplantation and Cellular Therapy3 citations Open access
Semantic Scholar
Impact of Gamma-Secretase Inhibition on Outcomes Following BCMA CAR-T Therapy in Multiple Myeloma: A Comparison of Two Phase 1 Trials.
A. Portuguese, S. Tuazon, Margot J. Pont, Gabriel O Cole +21 more
2025Transplantation and Cellular Therapy3 citations
Semantic Scholar
Early Prediction of Severe Icans after CD19 CAR T-Cell Therapy Based on Serum Ferritin Levels
Jennifer J. Huang, Emily C. Liang, Aya Albittar, A. Portuguese +17 more
2024Transplantation and Cellular Therapy3 citations Open access
Semantic Scholar
Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel: Efficacy and Toxicity in a Real-World Setting
A. Portuguese, Aya Albittar, Emily C. Liang, Jennifer J. Huang +14 more
2023Blood3 citations Open access
Semantic Scholar
Risk Factors for Pre-CAR-T Attrition Among Large B-Cell Lymphoma (LBCL) Patients
N. Wuliji, Rahul Banerjee, Emily C. Liang, Jennifer J. Huang +31 more
2024Transplantation and Cellular Therapy2 citations Open access
Semantic Scholar
An update on the overall epidemiology, clinical characteristics, and outcomes from the COVID-19 and Cancer Consortium (CCC19).
D. Shah, Pankil Shah, J. Warner, G. Batist +16 more
2022Journal of Clinical Oncology2 citations
Semantic Scholar
Transplant Onconephrology: An Update
Christopher D. Blosser, A. Portuguese, Cecilia Santana, N. Murakami
2022Seminars in Nephrology2 citations Open access
Semantic Scholar
The Impact of Extramedullary Multiple Myeloma on Treatment Outcomes with Teclistamab: U.S. Myeloma Immunotherapy Consortium Real World Experience
Aimaz Afrough, D. Dima, Beatrice M Razzo, Aishwarya Sannareddy +42 more
2025Transplantation and Cellular Therapy1 citations Open access
Semantic Scholar
High-Intensity Maintenance Post Autologous Stem Cell Transplant Is Independently Associated with Improved Event-Free Survival in Multiple Myeloma
I. Huang, Grace Baek, Gui-Zhen Chen, Omar Marzouk +8 more
2025Transplantation and Cellular Therapy1 citations Open access
Semantic Scholar
Phase 2 Trial of SC Versus IV Anakinra to Prevent CRS and Neurotoxicity in LBCL Patients Receiving Lisocabtagene Maraleucel: Final Analysis and Comparison to Historical Control
Emily C. Liang, Jennifer J. Huang, V. Ortíz-Maldonado, Aya Albittar +28 more
2025Transplantation and Cellular Therapy1 citations Open access
Semantic Scholar
P-007 Absolute Lymphocyte Count at Day 30 (Not Earlier) and Early CRS Predict Delayed Responses to Teclistamab: Results From the US Myeloma Immunotherapy Consortium
Rahul Banerjee, G. Kaur, Beatrice M Razzo, A. Portuguese +21 more
2024Clinical Lymphoma, Myeloma & Leukemia1 citations
Semantic Scholar
Identification and Prediction of Severe Hematologic Toxicity after CAR T-Cell Therapy Using Machine Learning-Based Time-Series Clustering
Emily C. Liang, Aya Albittar, A. Portuguese, Jennifer J. Huang +26 more
2024Transplantation and Cellular Therapy1 citations Open access
Semantic Scholar
Autoimmune Outcomes in Patients with Concurrent Autoimmune Disease Receiving CD19 CAR T-Cell Therapy for Lymphoma
Jennifer J. Huang, Namrata Singh, M. Shadman, Ryan S. Basom +15 more
2024Blood1 citations
Semantic Scholar
Identification of Predictors of CRS and Neurotoxicity Duration after Axicabtagene Ciloleucel Therapy
Aya Albittar, J. Voutsinas, A. Portuguese, Jennifer J. Huang +16 more
2024Transplantation and Cellular Therapy1 citations Open access
Semantic Scholar
Lisocabtagene maraleucel for relapsed or refractory large B-cell lymphoma: feasibility, safety and efficacy in a real-world setting
A. Portuguese, Aya Albittar, Emily C. Liang, Jennifer J. Huang +13 more
2023International Journal of Cancer Care and Delivery1 citations Open access
Semantic Scholar
Factors Associated with Prolonged CRS and Neurotoxicity after Treatment with Axicabtagene Ciloleucel
Aya Albittar, J. Voutsinas, A. Portuguese, Jennifer J. Huang +15 more
2023Blood1 citations
Semantic Scholar
P616: LONG-TERM FOLLOW-UP UPDATE AND MULTIVARIABLE ANALYSES OF FACTORS ASSOCIATED WITH DURATION OF RESPONSE AFTER CD19 CAR T-CELL THERAPY FOR RELAPSED/REFRACTORY CLL
Emily Liang, A. Hirayama, E. Kimble, A. Portuguese +10 more
2023HemaSphere1 citations Open access
Semantic Scholar
Machine Learning-Based Time-Series Clustering Identifies Archetypal Trajectories of Hematotoxicity after CAR T-Cell Therapy
Emily C. Liang, Aya Albittar, A. Portuguese, Jennifer J. Huang +24 more
2023Blood1 citations Open access
Semantic Scholar
Five-year follow-up update of defined-composition CD19 CAR T-cell therapy for relapsed/refractory CLL.
Emily C. Liang, A. Hirayama, E. Kimble, A. Portuguese +9 more
2023Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Idiopathic Post-CAR-T Hypotension: Prevalence and Management with Midodrine and/or Fludrocortisone
Christy Khouderchah, M. Karami, A. Portuguese, Rahul Banerjee +11 more
2026Transplantation and Cellular Therapy0 citations
Semantic Scholar
Superior Long-Term Survival with Fludarabine-Melphalan RIC Regimen in Older AML/MDS Patients: A Propensity Score Analysis of CIBMTR Data
Piyanuch Kongtim, A. Portuguese, Kim， Soyoung, Andrew Peterson +13 more
2026Transplantation and Cellular Therapy0 citations
Semantic Scholar
Early Relapse after Ciltacabtagene Autoleucel in High-Risk Multiple Myeloma: Implications for Risk-Adapted Therapy and Clinical Trial Design
D. Hansen, Lauren C. Peres, Danai Dima, S. Zanwar +60 more
2026Transplantation and Cellular Therapy0 citations
Semantic Scholar
NEMO: A Novel Prognostic Model of Non-Icans Neurotoxicities Associated with Ciltacabtagene Autoleucel
Yein Jeon, Xiancheng Wu, Christy Khouderchah, Emily C. Liang +13 more
2026Transplantation and Cellular Therapy0 citations
Semantic Scholar
Comprehensive Benchmarking of Outcomes after Anakinra Treatment for Refractory Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
Smith Kungwankiattichai, Emily C. Liang, Xiancheng Wu, J. Voutsinas +28 more
2026Transplantation and Cellular Therapy0 citations
Semantic Scholar
Outcomes of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS) in Patients Receiving Frontline Anakinra and Corticosteroids
Emily C. Liang, Dwight C Macero, Christy Khouderchah, J. Voutsinas +23 more
2026Transplantation and Cellular Therapy0 citations
Semantic Scholar
ALC Kinetics Velocity and Acceleration Are Early Predictors of Non-Icans Neurotoxicities after Cilta-Cel Treatment
Yein Jeon, Xiancheng Wu, Christy Khouderchah, Emily C. Liang +11 more
2026Transplantation and Cellular Therapy0 citations
Semantic Scholar
Feasibility, Safety and Efficacy of Early Redosing with CD19-Targeted CAR-T Cells in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
V. Ortíz-Maldonado, Emily C. Liang, Jennifer J. Huang, A. Hirayama +11 more
2025Transplantation and Cellular Therapy0 citations Open access
Semantic Scholar
Active Extramedullary Disease Predicts ICANS and Early ICAHT after CAR-T Therapy in Multiple Myeloma
A. Portuguese, Emily C. Liang, Jennifer J. Huang, L. Iovino +8 more
2025Transplantation and Cellular Therapy0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

A. Hirayama×25
Invite
A. Hirayama — researcher profile on SciRah
Jennifer J. Huang×24
Invite
Jennifer J. Huang — researcher profile on SciRah
Emily C. Liang×24
Invite
Emily C. Liang — researcher profile on SciRah
E. Kimble×23
Invite
E. Kimble — researcher profile on SciRah

×23

Invite

M. Shadman — researcher profile on SciRah

Invite

A. Chapuis — researcher profile on SciRah

R. Cassaday×21

Invite

R. Cassaday — researcher profile on SciRah

J. Gauthier×20

Invite

J. Gauthier — researcher profile on SciRah

Aya Albittar×18

Invite

Aya Albittar — researcher profile on SciRah

Filippo Milano×17

Invite

Filippo Milano — researcher profile on SciRah

Invite

D. Maloney — researcher profile on SciRah

Invite

L. Iovino — researcher profile on SciRah